Your browser doesn't support javascript.
loading
Trends in diabetic ketoacidosis in Victoria, Australia 2002-2016.
Jones, Hanna C; Kiburg, Katerina V; Lee, Melissa H; O'Neal, David N; MacIsaac, Richard J.
Affiliation
  • Jones HC; Department of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC, 3065, Australia.
  • Kiburg KV; Department of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC, 3065, Australia.
  • Lee MH; Department of Medicine, University of Melbourne, Fitzroy, VIC, 3065, Australia.
  • O'Neal DN; Department of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC, 3065, Australia.
  • MacIsaac RJ; Department of Medicine, University of Melbourne, Fitzroy, VIC, 3065, Australia.
BMC Endocr Disord ; 24(1): 128, 2024 Jul 29.
Article in En | MEDLINE | ID: mdl-39075462
ABSTRACT

BACKGROUND:

International longitudinal studies have indicated an increasing incidence of diabetic ketoacidosis (DKA). We aim to examine the incident trends, demographic differences, length of stay and mortality for DKA in adults with type 1 diabetes (T1D) and type 2 diabetes (T2D) in Victoria, Australia from 2002 to 2016.

METHODS:

Age and sex adjusted incident trends, length of stay and mortality for DKA was retrospectively obtained using the Victorian Admitted Episode Dataset between 2002 and 2016. Data for adults with T1D and T2D was obtained from the National Diabetes Services Scheme (NDSS). Joinpoint regression analysis was used to identify changes in linear trends that were described as average annual percentage change (AAPC).

RESULTS:

There were 23,628 DKA presentations in Victoria between 2002 and 2016. For T1D there was an increase in DKA presentations (AAPC + 6.8%) from 2003 to 2016 and for T2D there was a decline from 2003 to 2011 (APC - 3.5%), increase from 2011 to 2014 (APC + 38.5%), and a decrease from 2014 to 2016 (APC - 20.9%). Length of stay was longer for people with T2D than T1D (P < 0.001) and the mortality rate was 0.51% for the study period.

CONCLUSIONS:

DKA rates increased for T2D from 2011 to 2014 which correlates with the introduction of sodium glucose-linked transport protein 2 inhibitors. However, the aetiology for the observed increase in T1D from 2002 to 2016 remains unknown.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: BMC Endocr Disord Year: 2024 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: BMC Endocr Disord Year: 2024 Document type: Article Affiliation country: Australia